Retrospective Chinese NSCLC study links compound EGFR mutations to poorer TKI response
A retrospective single-center analysis of 452 Chinese patients with non-small cell lung cancer associated compound and co-occurring EGFR mutations with ...
A retrospective single-center analysis of 452 Chinese patients with non-small cell lung cancer associated compound and co-occurring EGFR mutations with ...
A 2026 literature review synthesizes clinical, diagnostic, molecular and therapeutic evidence on transformation from non–small cell lung cancer to small ...
In a two-center observational cohort of 120 patients with advanced NSCLC and COPD, higher serum IL-6 measured after six treatment ...
A 1,500-patient next-generation sequencing study from Gazi University reveals EGFR and KRAS as dominant drivers in advanced NSCLC, with distinct ...
A structured AGREE II appraisal of Iran's 2018 national NSCLC guideline found strong clarity of presentation but major weaknesses in ...
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, randomized, ...
A new systems-level study in 3D lung adenocarcinoma models shows that nutrient availability drives tumour cells into two distinct mitochondrial ...
A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK inhibitor combinations can ...
A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with chemotherapy in HER2-altered advanced NSCLC, while ...
A longitudinal spatial multi-omics study reveals how the tumor microenvironment in EGFR-mutant lung cancer remodels in distinct stages as patients ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine